Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-04
2006-04-04
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S368000, C514S300000, C514S600000, C514S254020, C548S154000, C548S151000, C546S121000, C544S318000, C544S133000
Reexamination Certificate
active
07022701
ABSTRACT:
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
REFERENCES:
patent: 5545644 (1996-08-01), Macor et al.
patent: 6133287 (2000-10-01), Slassi et al.
patent: 6187805 (2001-02-01), Pineiro et al.
patent: 6194410 (2001-02-01), Bös et al.
patent: 6403808 (2002-06-01), Glennon et al.
patent: WO 01/12629 (2001-02-01), None
patent: WO 01/32660 (2001-05-01), None
patent: WO 01/34146 (2001-05-01), None
Biniecki et al., “Synthesis of 1-(p-aminobenzoyl)-and 1-(2-quinolinoyl)-2-methyl-5-methoxy-3-indoleacetic acids and some amides thereof”, Acta Poloniae Pharmaceutica (1982), 39(1-3), 9-14.
Y. Tsai et al, N1-(Benzenesulfonyl)tryptamines as Novel 5-HT6Antagonists, Bioorganic & Medicinal Chemistry Letters 10 (2000) 2295-2299.
M. G. N. Russell et al, N-Arylsulfonylindole Derivatives as Serotonin 50HT6 Receptor Ligands, Journal of Medicinal Chemistry 44 (2001) 3881-3895.
R. A. Glennon et al, 2-Substituted Tryptamines: Agents with Selectivity for 5-HT6Serotonin Receptors, Journal of Medicinal Chemistry 43 (2000) 1011-1018.
Cole Derek Cecil
Lennox William Joseph
Stock Joseph Raymond
Zhou Ping
Lences Barbara L.
Ward Paul V.
Wilson James O.
Wyeth
LandOfFree
Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3569570